The current case-control study followed-up 100 patients with T2D without other risk factor from 1st January 2016 to 31st January 2017. Participants were recruited from diabetes outpatient’s clinic at Assuit University Hospitals, Assuit, Egypt. 50 healthy participants with similar age and sex characteristics that does not have a history of CIS, diabetes, or hypertension, dyslipidaemia and smoking were recruited to match controls. The following inclusion criteria were used: age > 18 years, patients with isolated T2D. Diabetes Mellitus (DM) diagnosis criteria was defined as fasting plasma glucose of ≥ 126 mg/dL, and/or 2-hr plasma glucose in the 75 g oral glucose tolerance test ≥ 200 mg/dL, random plasma glucose ≥ 200 mg/dL and HbA1c ≥ 6.5% (a criterion which is recommended by the World Health Organization) (
12).
Exclusion criteria were as follow: having history of CIS or Transient Ischemic Attacks (TIA), coexistence of other risk factors such as (hypertension, dyslipidaemia, cardiac diseases and smoking), and poor trans-cranial bone window. The study protocol was approved by the Ethical Committee of Assuit University according to principles of Helsinki Declaration. A written approval consent was taken from all participants.
A detailed history which included time since diabetes onset and its severity was obtained from all patients. Full neurological examination was performed. Laboratory workups were done for all patients, including serum glycosylated haemoglobin, complete blood count, lipid profile (serum triglycerides, cholesterol HDL and LDL), kidney function tests and liver function tests.
All member of case and control groups underwent a complete extracranial and intracranial ultrasound assessment by two experienced neurovascular sonographers. The ultrasound examination was done at the Neurovascular Ultrasound Laboratory in the Neurology department, Assiut University hospitals using a colour-coded duplex ultrasound device Philips HD5 (Philips Medical Systems, Nederland B.V.). Assessment was done for the carotid and vertebral arteries and for the intracranial arteries.
Intimal Medial Thickness (IMT) of the Common Carotid Artery (CCA), Peak Systolic Velocities (PSVs) and End Diastolic Velocities (EDVs) were also measured. Measurement was in the common, internal, and external carotid arteries (CCA, ICA, ECA) with L 3-12 MHz linear transducer probe. Stenosis and the velocities at the maximally stenotic area were also measured.
The intracranial arteries were evaluated in all patients by using Transcranial Color-Coded Duplex Sonography (TCCS) with the use of a low-frequency (2- to 5-MHz) phased-array probe through the transtemporal acoustic bone window. Middle Cerebral Artery (MCA), intracranial segment of vertebral artery (V4) and Basilar Artery (BA) were examined. To diagnose Intracranial Atherosclerotic Disease (ICAD), Peak Systolic Velocity (PSV) and flow direction (antegrade or reversed) were used.
The findings and the atherosclerotic changes in the extracranial and intracranial vessels are interpreted according to the internationally published data (
13,
14).
3.1. Statistical Analysis
Data are analysed by using SPSS software version 20.0. Before conducting analyses, the data normality was checked by using the Anderson-Darling test. Variance homogeneity was also checked. Categorical variables are described in absolute numbers and percentages (N, %). As well, continuous variables are described by mean and Standard Deviation (SD) (i.e. mean ± SD). Chi-square test and fisher exact test were used to compare categorical variables. To compare continuous variables t-test and independent-samples t test ANOVA were employed, followed by post hoc test. A two-tailed P value < 0.05 was considered as statistically significant (if P > 0.05, difference was non-significant). And if P < 0.001, difference was highly significant. Pearson and Spearman correlation were used to investigate associations between variables.